GlaxoSmithKline Faces Allegations in China

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

China Stock Market: 25 Years of Milestones
25:53 - Bloomberg takes a look at the last 25 years of stock market milestones for China. (Source: Bloomberg)
  • The Rise of South Korea's 'U-Turn Freshmen'
  • Earnest: The Modern Bank for the Next Generation?
  • 'Westgiving': The Feast Delivered by On Demand Startups